Aim: To define the effect of resveratrol (RES) on the central regulation of blood pressure (BP), heart rate (HR), and renal sympathetic nerve activity (RSNA). Methods: RES was microinjected into the rostral ventrolateral medulla (RVLM), and BP, HR, and RSNA were recorded simultaneously in anesthetized rats. Results: A microinjection of RES (20, 40, and 80 µmol/L, 0.2 µL) into the RVLM dose dependently decreased BP, HR, and RSNA. Pretreatment with an anti-estrogen tamoxifen (100 µmol/L, 0.2 µL) did not affect the effects of RES. Pretreatment with N G -nitro-L-arginine methyl ester (100 µmol/L, 0.2 µL), an inhibitor of nitric oxide (NO) synthase, could completely abolish the effect of RES. A prior microinjection of Bay K8644 (500 nmol/L, 0.2 µL), an agonist of calcium channels, could also abrogate the effect of RES. Prior administration of a potent inhibitor of tyrosine phosphatase, sodium orthovanadate (1 mmol/L, 0.2 µL), could partially attenuate the inhibitory effect of RES. Conclusion: The results suggest that a microinjection of RES into the RVLM inhibits BP, HR, and RSNA. The effects may be mediated by NO synthesis and a decrease in Ca 2+ influx, in which protein tyrosine kinase is involved.
Introduction
Resveratrol (3, 4',5-trihydroxystilbene; RES) is a naturally occurring phenolic substance present in a variety of plants, such as Polygonum cuspidatum roots, grapes and, red wine [1, 2] . It is also abundant in Chinese herbal medicines, including the cassia seed, hellebore, and giant knotweed rhizome [3] . RES has been reported to have a variety of estrogenic, antiinflammatory, antiplatelet, and anticarcinogenic effects [2, 4, 5] . Several recent studies showed the cardioprotective ability of RES [6] . Both in acute and in chronic models, RES protects the cardiovascular system against ischemic-reperfusion injury via locally released nitric oxide (NO) [7] , and it protects and maintains the intact endothelium and exhibits estrogenlike action [8] . Additionally, RES can induce vasorelaxation by inhibiting Ca 2+ influx [9] . Moreover, RES is thought to be one of the main causes of the well known "French paradox", which refers to the French suffering low rates of heart disease despite a diet relatively high in fat [10] . Thus RES may show potential clinical value in the treatment of cardiovascular disease as an alternative medicine.
It is generally accepted that the rostral ventrolateral medulla (RVLM) plays a pivotal role in the regulation of vascular tone and the maintenance of blood pressure (BP). The RVLM neurons have been shown to be involved in various sympathetic reflexes and the integration of the inputs from a variety of visceral, somatic, and supra medullary structures [11, 12] . It is a key region for the control of sympathetic drive to the periphery. The activity of RVLM neurons can dominate peripheral vascular tone and arterial BP. The RVLM is an important, possible link in the pathogenesis of hypertension, and in turn becomes a possible therapeutic target.
Previous studies have shown that RES has a beneficial effect on cardiovascular system via the peripheral mecha-nism [6] [7] [8] . The direct effects of RES on the cardiovascular center have not yet been examined. The RVLM is a key region of the cardiovascular center. The purpose of this study was to ascertain the effect of a microinjection of RES into the RVLM on sympathetic vasomotor tone by recording BP, heart rate (HR), and renal sympathetic nerve activity (RSNA), and to elucidate the possible central mechanism of its cardiovascular effects.
Materials and methods
The experiments were performed on 42 male SpragueDawley rats (300±5 g, Grade II) obtained from the Experimental Animal Center of Hebei, China. The rats were anesthetized by urethane (1.0 g/kg, ip). The trachea was cannulated for ventilation. Body temperature was maintained in the range of 37−38 ºC by a thermostatic bed.
Recording of BP, HR, and RSNA The left femoral artery was cannulated for recording BP by a pressure transducer (MPU-0.5 A; Nihon Kohden, Tokyo, Japan).The left kidney was exposed via a retroperitoneal approach. One branch of the renal sympathetic nerves around the renal vessels was clamped distally to eliminate the afferent activity. The nerve was placed on a bipolar silver electrode for potential recording and immersed in liquid paraffin. The pressure transducer and the bipolar silver electrode were connected with a set of biological polygraph (BL-420E + ; Chengdu Technology and Market, Chengdu, China) to record BP, HR, and RSNA simultaneously. RSNA was integrated automatically by computer, and the integrated time was 1.6 s. Upon the end of the experiment, the proximal end of the nerve was clamped to get the noise level of RSNA. The basal RSNA was the difference between the integral value of RSNA and the noise level. The difference was recorded as 100%. The data were expressed as the percentage change from basal value.
Exposure of the medulla ventral surface A midline incision was made on the ventral surface of the neck. The trachea and esophagus were transected in the lower neck and reflected rostrally. After retraction of the bilateral longus capitis muscles, the basilar portion of the occipital bone was removed. The ventral surface of the medulla was exposed by incising the dura and the arachnoid and then covered with warm (37 ºC) liquid paraffin. Cerebrospinal fluid was constantly drained with a strip of thinly twisted cotton.
Microinjection Anesthetized rats were fixed on a stereotaxic frame (Model IC; Jiangwan, Huaibei, China) in a supine position. A glass micropipette (tip diameter 10-30 µm) was inserted into the RVLM (stereotaxic coordinates [13] : 1.5-2.0 mm lateral to midline, 2.6-3.3 mm posterior to interaural line, and 0.3-0.5 mm from the ventral surface of medulla oblongata) for the microinjection. The injection filled in the micropipette was delivered into the left RVLM unilaterally by a nanoliter injector (A203XVZ; World Precision, Sarasota, Florida, USA). By regulating the injection mode of the injector, the injection volume (200 nL) was divided into 8 parts and delivered separately with an interval of 1 min (25 nL per time).
Histological examination To identify the site of microinjection postmortem, 2% pontamine sky blue was added to the injection. At the completion of the experiments, the animals were deeply anesthetized, and the brainstem was removed and stored in 10% formalin solution. After 7-10 d, the frozen brain tissue was sectioned in the coronal plane (40 µm). Histological verification was carried out with reference to Paxinos and Watson's coordinates [13] . The stained area or the depth of the injecting track in the RVLM was examined under a microscope. The results from the animals with injection diffusing out of the RVLM were excluded from statistic data.
Protocols A period of 30 min was allowed for stabilization after the operation. After a stable recording was obtained for more than 5 min, the vehicle was used as the control. After 15 min, RES at 20, 40, and 80 µmol/L (0.2 µL) was microinjected into the RVLM to examine the effects of different doses of RES on BP, HR, and RSNA. One dose was only tested in each rat.
The effect of tamoxifen (TAM), an estrogen receptor blocking agent, on the response to RES was examined. After the control parameters were obtained, RES (40 µmol/L, 0.2 µL) was microinjected into the RVLM. BP, HR, and RSNA were measured. Approximately 50 min later, after the parameters recovered to baseline for at least 10 min, TAM (100 µmol/L, 0.2 µL) was microinjected into the RVLM and the parameters were obtained. After 15 min, a microinjection of RES (40 µmol/L, 0.2 µL) into the RVLM was carried out again. To determine whether NO was involved, N G -nitro-L-arginine methyl ester (L-NAME; 100 µmol/L, 0.2 µL) was microinjected into the RVLM to observe the effect of L-NAME on that of RES. To determine whether Ca 2+ was involved, BP, HR, and RSNA were examined following the administration of RES (40 µmol/L, 0.2 µL) before and after the microinjection of Bay K8644 (500 nmol/L, 0.2 µL), an agonist of calcium channels, into the RVLM. To further determine the involvement of protein tyrosine kinase (PTK), one experimental group was treated with sodium orthovanadate (1 mmol/L, 0.2 µL) for 15 min before RES was microinjected.
Drugs RES (purity 99%; Sigma, St Louis, MO, USA) was dissolved in DMSO. TAM (Sigma, USA) and Bay K8644 (Sigma, USA) were dissolved in 99% ethyl alcohol. The final concentration of DMSO or ethyl alcohol in the injection was lower than 0.05%. L-NAME (Sigma, USA) and sodium orthovanadate (Sigma, USA) were dissolved in saline. No changes in BP, HR, and RSNA were observed during the microinjection with DMSO (1:2000) or ethyl alcohol (1:2000) .
Statistics All values are presented as mean±SEM. The significance of differences between groups was determined by one-way ANOVA and further analyzed by StudentNewman-Kuels test and Dunnett's t-test. Differences were considered statistically when P<0.05.
Results
A total of 42 male rats were used in the present study. Figure 1 presents the medullary coronal section summarizing the locations of the RVLM sites for RES microinjection.
Effects of RES on BP, HR, and RSNA (n=6)
The microinjection of RES (20, 40 , and 80 µmol/L) into the RVLM decreased BP, HR, and RSNA in a dose-dependent manner (Figures 2, 3) . The effect started within 10 min, reached its peak within 15-25 min, and lasted for 30-40 min. The vehicle of RES (0.05% DMSO in saline) showed no effect on the above parameters (n=6).
RES (40 µmol/L) produced moderate inhibitory effects on BP, HR, and RSNA. The parameters could completely recover within 25-30 min. This concentration was effective and did not produce irreversible damage. It was conducive to observe the response of cardiovascular activities induced by RES to these pretreatments. Therefore, we chose 40 µmol/L RES for the mechanistic evaluation.
Effects of TAM on RES responses (n=6) In 6 anesthetized rats, the application of RES (40 µmol/L) into the RVLM decreased BP, HR, and RSNA to 76.50%, 93.93%, and 65.32% of the control, respectively. After recovering from the effects of RES, TAM (100 µmol/L) was administered into (Figure 4 ). The vehicle of TAM (0.05% ethyl alcohol in saline) was microinjected in another group and showed no significant effect on BP, HR, and RSNA (n=6).
Effects of L-NAME on RES responses (n=6) RES (40 µmol/L) was microinjected into the RVLM. BP, HR, and RSNA decreased. After recovering from the effects of RES, L-NAME (100 µmol/L) was administered into the RVLM and showed no significant effect on the above parameters ( . The results suggested that the effect of RES in the RVLM might be completely blocked by L-NAME ( Figure 5 ).
The vehicle of L-NAME (the normal saline) was tested in another group and did not produce any change in the parameters (n=6).
Effect of Bay K8644 on RES responses (n=6)
The effects of RES (40 µmol/L) were observed first, and BP, HR, and RSNA decreased to 76.19%, 93.98%, and 67.33% of the control, respectively. After recovering from the effects of RES, Bay K8644 (500 nmol/L) was microinjected into the RVLM, and the parameters showed no significant change [ (Figure 6 ). The vehicle of Bay K8644 (0.05% ethyl alcohol in saline) showed no significant effect on BP, HR, and RSNA (n=6).
Effects of sodium orthovanadate on RES responses (n=6) RES (40 µmol/L) was microinjected into the RVLM. BP, HR, (Figure 7 ). The vehicle of sodium orthovanadate (the normal saline) did not produce any change in the parameters (n=6). The microinjection vehicle of RES (600 nL) into the RVLM had no significant effect on BP, HR, and RSNA (n=6). Therefore, changes caused by mechanical damage could be ruled out.
Discussion
The present study demonstrates that RES inhibits BP, HR, and RSNA in a concentration-dependent manner. It is well established that the sympathetic-related neurons in the RVLM innervate cholinergic preganglionic sympathetic neurons in the spinal cord, and stimulation of the RVLM increases arterial BP and sympathetic outflow [14] . The RVLM can continue to drive sympathetic nerve activity to regulate arterial BP in the chronic absence of baroreceptor input in baroreceptor-denervated rats [15] . It is a key region for the control of sympathetic drive to the periphery. The inhibitory effect of RES on the RVLM means that RES can decrease the sympathetic outflow of RVLM, resulting in a decrease of arterial BP. RES may show potential clinical value in the treatment of hypertension and other related cardiovascular diseases as an inhibitor of the sympathetic nerve center.
RES is a kind of phytoestrogen and can exert genomic and non-genomic actions on target tissues via estrogen receptors [16] . The α and β forms of estrogen receptors have been cloned from human and rats, which have been identified in a wide range of tissues, including the cardiovascular system and central nervous system. Multiple brain regions concerning central cardiovascular regulation, including nu- clei tractus solitarii, ventrolateral medulla, and area postrema, contain both forms of estrogen receptors [17] . The anti-estrogen TAM, which acts by binding to estrogen receptors and has been shown to prevent classic estrogen effects, did not influence the inhibitory effect of RES on the RVLM neurons. Thus the observed effect of RES in our experiments might act in a rapid, non-genomic mechanism and might not be attributed to estrogen receptor mediation.
NO is a novel messenger in the central nervous system and has an important influence on the RVLM and sympathetic nerve activity [18] , Chan et al found that NO synthase (NOS) I, II, and III were expressed in the RVLM [19] . The increase of NO production caused by the overexpression of NOS III in the bilateral RVLM could decrease BP, HR, and RSNA [20] . Kiziltepe's study shows that RES can upregulate NO in the spinal cord [21] . Furthermore, our previous work has demonstrated that RES can inhibit the electrical activity of subfornical organs [22] and hippocampal CA1 area [23] neurons induced by L-NAME via locally-produced NO. In the present study, pretreatment with L-NAME, a non-selective inhibitor of NOS, completely blocked the action of RES, thus suggesting that RES exerts its inhibitory effects on the RVLM via increasing the synthesis of NO.
It is well known that NO can inhibit the Ca 2+ influx in neurons [24] . We used Bay K8644, an agonist of calcium channels, to further determine the involvement of Ca 2+ . The fact that Bay K8644 completely blocks the inhibitory effect of RES on the RVLM in our study strongly suggests that the inhibitory effects of RES might be due to the blockade of calcium influx. This result is consistent with that of our previous study, which shows that RES can affect the calcium channel and significantly inhibit Ca 2+ influx into subfornical organs [22] and hippocampal CA1 area [23] neurons. Gong's study also shows that RES can inhibit intracellular free Ca 2+ concentration in rat primary neuron cultures [25] . Considering that Bay K8644 is a selective L-type voltagegated calcium channel agonist, this inhibitory effect might be mainly due to the blockade of the L-type voltage-gated calcium channel. Therefore, it may be proposed that RES might increase the production of NO and subsequently inhibit Ca 2+ influx through the L-type voltage-gated calcium channel.
RES has been proven to be an inhibitor of PTK [26] . PTK activity is a major signaling mechanism in regulating cell growth, division, metabolism, and ion channel conductance [27] . Evidence has been presented to suggest that the intracellular Ca 2+ through the L-type voltage-gated calcium channel can activate PTK in neurons [28] [29] [30] . Sodium orthovanadate, an inhibitor of tyrosine phosphatase, can enhance protein tyrosine phosphorylation. Our present study shows that sodium orthovanadate partially abolishes the inhibitory effects of RES on BP, HR, and RSNA, suggesting that the PTK pathway is involved. Taken together, our data and previous findings, infer that RES increases NO synthesis, attenuates Ca 2+ influx through the L-type voltage-gated calcium channel, and then inhibits PTK in the RVLM neurons.
In summary, the present study has revealed that RES inhibits the RVLM and decreases sympathetic vasomotor tone. It is also possible that the altered excitability of the RVLM neurons induced by the NOS inhibitor, calcium channel agonist, or PTK inhibitor also desensitizes the RVLM neuronal response to RES and then reduces the RES effects.
